Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension study of insulin glargine + sitagliptin in type 2 diabetes inadequately controlled after LANTU_C_02761
2008-000521-19Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jun 2008
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, single-arm trial of insulin glargine and sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Primary endpoint: Primary efficacy endpoint. Started Jun 2008; status: completed.
02
Drugs
insulin glarginesitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2008-000521-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000521-19.